BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 25217549)

  • 1. Analysis of Δ9-tetrahydrocannabinol driving under the influence of drugs cases in Colorado from January 2011 to February 2014.
    Urfer S; Morton J; Beall V; Feldmann J; Gunesch J
    J Anal Toxicol; 2014 Oct; 38(8):575-81. PubMed ID: 25217549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Driving Under the Influence of Marijuana Versus Driving and Dying Under the Influence of Marijuana: A Comparison of Blood Concentrations of Δ9-Tetrahydrocannabinol, 11-Hydroxy-Δ9-Tetrahydrocannabinol, 11-Nor-9-Carboxy-Δ9-Tetrahydrocannabinol and Other Cannabinoids in Arrested Drivers Versus Deceased Drivers.
    Lemos NP; San Nicolas AC; Volk JA; Ingle EA; Williams CM
    J Anal Toxicol; 2015 Oct; 39(8):588-601. PubMed ID: 26378132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential physiological and behavioral cues observed in individuals smoking botanical marijuana versus synthetic cannabinoid drugs.
    Chase PB; Hawkins J; Mosier J; Jimenez E; Boesen K; Logan BK; Walter FG
    Clin Toxicol (Phila); 2016; 54(1):14-9. PubMed ID: 26653952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Driving under the influence of cannabis: a 10-year study of age and gender differences in the concentrations of tetrahydrocannabinol in blood.
    Jones AW; Holmgren A; Kugelberg FC
    Addiction; 2008 Mar; 103(3):452-61. PubMed ID: 18190663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delays in DUI blood testing: Impact on cannabis DUI assessments.
    Wood E; Brooks-Russell A; Drum P
    Traffic Inj Prev; 2016; 17(2):105-8. PubMed ID: 26066003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of Δ9-tetrahydrocannabinolic acid A (Δ9-THCA-A) in whole blood and plasma by LC-MS/MS and application in authentic samples from drivers suspected of driving under the influence of cannabis.
    Raikos N; Schmid H; Nussbaumer S; Ambach L; Lanz S; Längin A; König S; Roth N; Auwärter V; Weinmann W
    Forensic Sci Int; 2014 Oct; 243():130-6. PubMed ID: 25173986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of marijuana in suspected impaired driving cases in Washington state.
    Couper FJ; Peterson BL
    J Anal Toxicol; 2014 Oct; 38(8):569-74. PubMed ID: 25217548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Usefulness of the initial medical examination on matters relating to persons suspected of driving under the influence of amphetamine and its analogs or delta9-tetrahydrocannabinol based on the materials the Department of Forensic Medicine, Pomeranian Medical University in Szczecin].
    Wolski S; Lewandowska E; Kurzejamska-Parafiniuk M
    Ann Acad Med Stetin; 2013; 59(2):147-56. PubMed ID: 25026768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Δ(9) -tetrahydrocannabinol detection using DrugWipe5S(®) screening and oral fluid quantification after Quantisal™ collection for roadside drug detection via a controlled study with chronic cannabis users.
    Wille SM; Di Fazio V; Toennes SW; van Wel JH; Ramaekers JG; Samyn N
    Drug Test Anal; 2015 Mar; 7(3):178-86. PubMed ID: 24753449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabis findings in drivers suspected of driving under the influence of drugs in Finland from 2006 to 2008.
    Blencowe T; Pehrsson A; Mykkänen S; Gunnar T; Lillsunde P
    Forensic Sci Int; 2012 Apr; 217(1-3):107-12. PubMed ID: 22024655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoids determination in oral fluid by SPME-GC/MS and UHPLC-MS/MS and its application on suspected drivers.
    Anzillotti L; Castrignanò E; Strano Rossi S; Chiarotti M
    Sci Justice; 2014 Dec; 54(6):421-6. PubMed ID: 25498928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Driving under the influence of cannabis: pitfalls, validation, and quality control of a UPLC-MS/MS method for the quantification of tetrahydrocannabinol in oral fluid collected with StatSure, Quantisal, or Certus collector.
    Wille SM; Di Fazio V; Ramírez-Fernandez Mdel M; Kummer N; Samyn N
    Ther Drug Monit; 2013 Feb; 35(1):101-11. PubMed ID: 23318281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between self-report of cannabis use and toxicological detection of THC/THCCOOH in blood and THC in oral fluid in drivers in a roadside survey.
    Van der Linden T; Silverans P; Verstraete AG
    Drug Test Anal; 2014; 6(1-2):137-42. PubMed ID: 23939912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary excretion profiles of 11-nor-9-carboxy-delta9-tetrahydrocannabinol and 11-hydroxy-delta9-THC: cannabinoid metabolites to creatinine ratio study IV.
    Fraser AD; Worth D
    Forensic Sci Int; 2004 Jul; 143(2-3):147-52. PubMed ID: 15240035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency and irregularity of heart rate in drivers suspected of driving under the influence of cannabis.
    Khiabani HZ; Mørland J; Bramness JG
    Eur J Intern Med; 2008 Dec; 19(8):608-12. PubMed ID: 19046727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postmortem redistribution of Δ9-tetrahydrocannabinol (THC), 11-hydroxy-THC (11-OH-THC), and 11-nor-9-carboxy-THC (THCCOOH).
    Holland MG; Schwope DM; Stoppacher R; Gillen SB; Huestis MA
    Forensic Sci Int; 2011 Oct; 212(1-3):247-51. PubMed ID: 21764230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Has the intake of THC by cannabis users changed over the last decade? Evidence of increased exposure by analysis of blood THC concentrations in impaired drivers.
    Vindenes V; Strand DH; Kristoffersen L; Boix F; Mørland J
    Forensic Sci Int; 2013 Mar; 226(1-3):197-201. PubMed ID: 23415163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetrahydrocannabinol and two of its metabolites in whole blood using liquid chromatography-tandem mass spectrometry.
    Coulter C; Miller E; Crompton K; Moore C
    J Anal Toxicol; 2008 Oct; 32(8):653-8. PubMed ID: 19007517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First nationwide study on driving under the influence of drugs in Switzerland.
    Senna MC; Augsburger M; Aebi B; Briellmann TA; Donzé N; Dubugnon JL; Iten PX; Staub C; Sturm W; Sutter K
    Forensic Sci Int; 2010 May; 198(1-3):11-6. PubMed ID: 20211534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do Delta9-tetrahydrocannabinol concentrations indicate recent use in chronic cannabis users?
    Karschner EL; Schwilke EW; Lowe RH; Darwin WD; Pope HG; Herning R; Cadet JL; Huestis MA
    Addiction; 2009 Dec; 104(12):2041-8. PubMed ID: 19804462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.